JMC's CEO, Justin Choi, recently attended IMCAS Paris 2025, one of the world’s leading congresses in aesthetics and dermatology. This prestigious event provided an excellent opportunity for JMC to showcase its premium aesthetic solutions and strengthen its presence in the global market.
During the event, Justin Choi engaged in insightful discussions with industry leaders, distributors, and medical professionals, highlighting JMC’s own brand portfolio, including Ve age and MesoverA. These conversations focused on the latest trends in medical aesthetics, potential collaborations, and expansion strategies.
As JMC continues to grow, participation in major global conferences like IMCAS Paris 2025 plays a vital role in shaping the company’s future in the medical aesthetics industry. Stay tuned for more updates on JMC’s journey toward innovation and global expansion.